A carregar...
Does it Matter Whether or Not a Lipid-Lowering Agent Inhibits Rho Kinase?
Lipid lowering agents, such as HMG CoA reductase inhibitors or statins, have been shown to reduce cardiovascular events. However, growing evidence from recent clinical trials suggest that some of the beneficial effects of statins may be unrelated to changes in LDL-C. In animal studies, many of the c...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2643375/ https://ncbi.nlm.nih.gov/pubmed/18001621 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|